Olympus Corporation and Danaher (Leica Biosystems) – Notable Market Players in Whole Slide Imaging Market
Whole slide imaging technology deals with the acquisition of high-speed, high-resolution slide images for pathology workflow. The technology is also known as virtual pathology and plays major role in the digital pathology. Whole slide imaging is responsible for image archiving and sharing. In addition, pathologists can also utilize these images for diagnosis by generating digital workflow.
Key driving factors include the technological advancements in whole slide imaging and increase in adoption of digital pathology. However, the high cost involved in the installation and maintenance of whole slide imaging is expected to hinder the market growth.
The Whole Slide Imaging market is majorly comprised of top players involving 3DHISTECH Ltd., Indica Labs, Inspirata, Inc., Koninklijke Philips N.V., Hamamatsu Photonics K.K., Olympus, Nikon, Danaher (Leica Biosystems), Mikroscan Technologies, Inc., Visiopharm AS, and Akoya Biosciences, Inc. among others.
The companies listed above are implementing various strategies such as product launches, acquisitions, mergers, and partnerships, which have resulted in the company’s growth and, in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.
Below is the list of the growth strategies done by the players operating in the whole slide imaging market:
| Year | News |
| July -2022 | The new OmniScan X3 64 flaw detector delivers improved power and performance to Olympus’ field-proven phased array ultrasonic testing (PAUT) product line. This 64-channel instrument has the capacity to drive phased array (PA) probes with a larger number of elements, increasing the data acquisition speed for total focusing method (TFM) imaging. Users can exploit its increased capabilities to expand and diversify their application portfolio. |
| September -2020 | Akoya Biosciences, Inc., announced the availability of Proxima, to incorporate rapid image acquisition and secure data sharing in the cloud with instant access from anywhere for geographically distributed and remote teams, including those working from home during the COVID-19 pandemic. |
| May-2022
|
Cancer informatics provider Inspirata announced that it has become a member of the Advarra Partner Program. As an inaugural API Gold partner, Inspirata will collaborate closely with Advarra’s engineering and support teams on ensuring out-of-the-box integrations between OnCore, an Advarra CTMS solution, and Trial Navigator, Inspirata’s fully automated, NLP-powered clinical trial matching offering. |
| March-2022 | Proscia, a leader in digital and computational pathology solutions, and Visiopharm, a world leader in AI-driven precision pathology software, today announced a strategic partnership to deliver integrated AI-enabled solutions that aim to improve clinical decision-making for cancer care. Through the collaboration, the partners will advance the use of AI-enabled solutions to deliver new insights to pathologists for two of the most common cancer diagnoses. |
| June-2021 | Akoya plans to collaborate with its imaging partners to further expand integration of the CODEX system with the latest and most advanced microscopy platforms. The benefits of the partnerships should include a more streamlined user experience, new workflows, faster acquisition speeds, and deeper resolution. |
